Parametric Portfolio Associates’s Catalyst Pharmaceutical CPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $2.83M | Buy |
341,584
+175,361
| +105% | +$1.45M | ﹤0.01% | 2227 |
|
2021
Q4 | $1.13M | Sell |
166,223
-2,175
| -1% | -$14.7K | ﹤0.01% | 2730 |
|
2021
Q3 | $893K | Buy |
168,398
+2,676
| +2% | +$14.2K | ﹤0.01% | 2846 |
|
2021
Q2 | $953K | Sell |
165,722
-41,533
| -20% | -$239K | ﹤0.01% | 2788 |
|
2021
Q1 | $955K | Buy |
207,255
+87,726
| +73% | +$404K | ﹤0.01% | 3182 |
|
2020
Q4 | $399K | Buy |
119,529
+2,344
| +2% | +$7.83K | ﹤0.01% | 3474 |
|
2020
Q3 | $348K | Buy |
117,185
+29,487
| +34% | +$87.6K | ﹤0.01% | 3428 |
|
2020
Q2 | $405K | Buy |
87,698
+38,345
| +78% | +$177K | ﹤0.01% | 3356 |
|
2020
Q1 | $190K | Sell |
49,353
-12,655
| -20% | -$48.7K | ﹤0.01% | 3571 |
|
2019
Q4 | $233K | Buy |
62,008
+49,429
| +393% | +$186K | ﹤0.01% | 3681 |
|
2019
Q3 | $67K | Buy |
+12,579
| New | +$67K | ﹤0.01% | 3882 |
|
2019
Q2 | – | Sell |
-186,708
| Closed | -$952K | – | 3961 |
|
2019
Q1 | $952K | Buy |
+186,708
| New | +$952K | ﹤0.01% | 3058 |
|
2018
Q1 | – | Sell |
-261,325
| Closed | -$1.02M | – | 3937 |
|
2017
Q4 | $1.02M | Buy |
+261,325
| New | +$1.02M | ﹤0.01% | 3011 |
|